Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
AIMS/HYPOTHESIS: Epidemiological studies have shown that diabetes is a well-established independent but modifiable risk factor for stroke. The aim of this post hoc analysis of data from the Steno-2 Study was to examine whether multiple risk factor intervention reduced the risk for stroke in individuals with type 2 diabetes and microalbuminuria. METHODS: In the Steno-2 Study, 160 individuals with type 2 diabetes and microalbuminuria were randomised to intensified or conventional multiple risk factor intervention, targeting classical cardiovascular disease risk factors for a mean of 7.8 years, and then followed for a total mean of 21.2 years. The primary endpoint in this post hoc analysis was time to first stroke event. RESULTS: During follow-up, 30 participants experienced a total of 39 strokes. Individuals randomised to conventional therapy were more likely to experience a stroke than those in the intensive-therapy group, with 29 total strokes occurring in 21 participants (26%) in the conventional-therapy group vs a total of ten strokes in nine participants (11%) in the intensive-therapy group (HR 0.31 [95% CI 0.14, 0.69]; p = 0.004). Also, the number of recurrent strokes was significantly reduced with intensive therapy. CONCLUSIONS/INTERPRETATION: Intensified multiple risk factor intervention in patients with type 2 diabetes and microalbuminuria reduces the risk for strokes as well as the number of recurrent cerebrovascular events. TRIAL REGISTRATION: ClinicalTrials.gov NCT00320008.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 CONSORT diagram showing participant flow throughout the Steno-2 trial. The first 7.8 years were the active intervention period, after which time the randomisation was neutralised and continued as a post-trial observational follow-up study with all remaining participants being offered the same treatment as the original intensive-therapy group. At the time of randomisation, the mean age was 55.1 years and 66% were male. All participants had microalbuminuria. Reproduced from [8] under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium](https://figures.cochat.ai/paper-figures/5006d5ed5f7142e9b22a7c953ec19189/beneficial-impact-of-intensified-multifactorial-intervention-on-risk-of-stroke-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, a post hoc analysis of the landmark Steno-2 study (Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria) reported that an aggressive multi-risk factor approach significantly reduced micro-and macro-vascular complications, including time to first stroke event (hazard ratio [HR], 0.31 [95% CI, 0.14-0.69];P=0.004), compared with conventional care.2”
From Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists (2022) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Changes in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749
Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016
Collaborators, T. G. 2. L. R. O. S. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804492 · Cited by 1,503
Intercapillary Lesions in the Glomeruli of the Kidney.
Kimmelstiel, P., & Wilson, C. (1936) · PubMed · Cited by 661
Gæde, P., Oellgaard, J., Carstensen, B., Rossing, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2016) · Diabetologia · doi:10.1007/s00125-016-4065-6 · Cited by 528
Self-citationChanges in Diabetes-Related Complications in the United States
(2014) · New England Journal of Medicine · doi:10.1056/nejmc1406009 · Cited by 326
Lacunar Infarction and Small Vessel Disease: Pathology and Pathophysiology
Caplan, L. R. (2015) · Journal of Stroke · doi:10.5853/jos.2015.17.1.2 · Cited by 237
Oellgaard, J., Gæde, P., Rossing, P., Rørth, R., Køber, L., Parving, H.-H., & Pedersen, O. (2018) · Diabetologia · doi:10.1007/s00125-018-4642-y · Cited by 86 · cited 1×
“Reproduced from [8] under the terms of the Creative Commons Attribution 4.”
Self-citationGæde, J., Oellgaard, J., Ibsen, R., Gæde, P., Nørtoft, E., Parving, H., Kjellberg, J., & Pedersen, O. B. (2018) · Diabetologia · doi:10.1007/s00125-018-4739-3 · Cited by 21
Self-citationGæde, P. (2006) · PubMed · Cited by 10
Self-citation
Cited by
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
Palaniappan, L. P., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 242
Diabetes and Stroke: What Are the Connections?
Mosenzon, O., Cheng, A. Y., Rabinstein, A. A., & Sacco, S. (2023) · Journal of Stroke · doi:10.5853/jos.2022.02306 · Cited by 249
Wright, A. K., Suarez-Ortegon, M. F., Read, S. H., Kontopantelis, E., Buchan, I., Emsley, R., Sattar, N., Ashcroft, D. M., Wild, S. H., & Rutter, M. K. (2020) · Circulation · doi:10.1161/circulationaha.120.046783 · Cited by 117
Goldenberg, R. M., Cheng, A. Y. Y., Fitzpatrick, T., Gilbert, J. D., Verma, S., & Hopyan, J. J. (2022) · Stroke · doi:10.1161/strokeaha.121.038151 · Cited by 82
Metadata
- Authors
- Gæde, P., Oellgaard, J., Kruuse, C., Rossing, P., Parving, H.-H., & Pedersen, O.
- Affiliations
- University of Southern Denmark (DK)
- Novo Nordisk (Denmark) (DK)
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Pedersen, Oluf
- Venue
- Diabetologia
- Published
- 2019-06-01
- Volume
- 62
- Issue
- 9
- Pages
- 1575-1580
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC6677690
- OpenAlex
- W2946973680
- Cited by
- 29
- References
- 9
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 4 · 2020: 7
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Diabetologia (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by)
- Funders
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- stroke risk, type 2 diabetes, microalbuminuria, stroke recurrence, cerebrovascular events, long-term follow-up
- MeSH terms
- Albuminuria, Combined Modality Therapy, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Hypoglycemic Agents, Male, Risk Factors, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study. https://app.cochat.ai/papers/10.1007/s00125-019-4920-3
- The paper
- Gæde, P., Oellgaard, J., Kruuse, C., Rossing, P., Parving, H.-H., & Pedersen, O. (2019). Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study. Diabetologia. https://doi.org/10.1007/s00125-019-4920-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.